Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02867618
Title Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Changchun Deng
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Carfilzomib + Umbralisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.